We are live on ! Find out more
HRMY icon

Harmony Biosciences
HRMY

204 hedge funds and large institutions have $1.62B invested in Harmony Biosciences in 2023 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 86 increasing their positions, 56 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

119% more call options, than puts

Call options by funds: $9.47M | Put options by funds: $4.32M

54% more repeat investments, than reductions

Existing positions increased: 86 | Existing positions reduced: 56

3% less funds holding

Funds holding: 211 → 204 (-7)

4.31% less ownership

Funds ownership: 86.69% → 82.38% (-4.3%)

11% less capital invested

Capital invested by funds: $1.83B → $1.62B (-$205M)

14% less funds holding in top 10

Funds holding in top 10: 7 → 6 (-1)

18% less first-time investments, than exits

New positions opened: 32 | Existing positions closed: 39

Holders
204
Holders Change
-7
Holders Change %
-3.32%
% of All Funds
3.24%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.1%
New
32
Increased
86
Reduced
56
Closed
39
Calls
$9.47M
Puts
$4.32M
Net Calls
+$5.15M
Net Calls Change
+$9.9M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$13.3M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$7.64M
3
PA
Perceptive Advisors
New York
+$3.64M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$3.07M
5
State Street
State Street
Massachusetts
+$3M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$19.4M
2
Pacer Advisors
Pacer Advisors
Pennsylvania
-$15.2M
3
Millennium Management
Millennium Management
New York
-$13.3M
4
Man Group
Man Group
United Kingdom
-$11.1M
5
American Century Companies
American Century Companies
Missouri
-$9.28M
Name Holding Trade Value Shares
Change 		Change in
Stake
AF
201
Advisornet Financial
Minnesota
$131 -$35 -1 -20%
AF
202
Allworth Financial
California
$99 -$868 -25 -89%
TWP
203
TFO Wealth Partners
Ohio
$35 – – –
MHR
204
Matthew Hamilton Rosenberg
$33 – – –
TCM
205
Tributary Capital Management
Nebraska
– -$7.26M -206,218 Closed
Walleye Capital
206
Walleye Capital
New York
– -$6.9M -196,200 Closed
Schroder Investment Management Group
207
Schroder Investment Management Group
United Kingdom
– -$3.75M -106,527 Closed
CSS
208
Cubist Systematic Strategies
Connecticut
– -$3.01M -85,633 Closed
Bank of Montreal
209
Bank of Montreal
Ontario, Canada
– -$2.91M -79,754 Closed
TI
210
Trexquant Investment
Connecticut
– -$2.02M -57,468 Closed
LCG
211
Lisanti Capital Growth
New York
– -$1.93M -54,800 Closed
AIMCA
212
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
– -$1.49M -42,332 Closed
Wellington Management Group
213
Wellington Management Group
Massachusetts
– -$1.47M -41,720 Closed
Tudor Investment Corp
214
Tudor Investment Corp
Connecticut
– -$1.06M -30,142 Closed
Envestnet Asset Management
215
Envestnet Asset Management
Illinois
– -$951K -27,032 Closed
ADIM
216
Alpha DNA Investment Management
Maryland
– -$712K -20,242 Closed
Walleye Trading
217
Walleye Trading
New York
– -$519K -14,762 Closed
GCM
218
Graham Capital Management
Connecticut
– -$513K -14,585 Closed
AWM
219
AE Wealth Management
Kansas
– -$510K -14,487 Closed
M1FG
220
Mach-1 Financial Group
Arkansas
– -$485K -13,769 Closed
WMSA
221
Weiss Multi-Strategy Advisers
New York
– -$352K -10,015 Closed
JFG
222
Jefferies Financial Group
New York
– -$352K -10,000 Closed
SGI
223
Summit Global Investments
Utah
– -$346K -9,827 Closed
AIM
224
Aigen Investment Management
New York
– -$309K -8,788 Closed
FNBOO
225
First National Bank of Omaha
Nebraska
– -$301K -8,547 Closed
6 7 8
9
10

HRMY Hedge Fund Activity: Q3 2023 in Review

204 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Harmony Biosciences (HRMY) for Q3 2023, worth a combined $1.62B — down 11% from $1.83B a quarter earlier.

Sellers outnumbered buyers: 39 funds closed out of HRMY and 32 opened new positions — a net loss of 7 holders — while 56 trimmed existing stakes and 86 added.

The largest buyer was BlackRock, adding an estimated $13.3M. The largest seller was Citadel Advisors, cutting an estimated $19.4M.

  • 204 institutional investors held Harmony Biosciences (HRMY) as of Q3 2023, down from 211 in Q2 2023.
  • Funds reported $1.62B of Harmony Biosciences stock for Q3 2023, down 11% quarter-over-quarter.
  • 32 funds opened new Harmony Biosciences positions in Q3 2023 and 39 closed out, a net change of -7 holders.
  • The largest Harmony Biosciences buyer in Q3 2023 was BlackRock, an estimated $13.3M added.
  • The largest Harmony Biosciences seller in Q3 2023 was Citadel Advisors, an estimated $19.4M sold.

Based on aggregated 13F filings for Q3 2023.